Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
S
Sharmilan Thanendrarjan
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
1 pubs
Research Areas
Biography and Research Information
OverviewAI-generated summary
Sharmilan Thanendrarjan's research focuses on the prognostic impact of immune cell kinetics and composition during bispecific antibody therapy for relapsed/refractory multiple myeloma. His work has been published in 2026, and he has a total of one publication. Thanendrarjan collaborates with several researchers at the University of Arkansas for Medical Sciences, including Hira Imad Cheema, Syed Naqvi, Sasya Dronavalli, and Asis Shrestha, with whom he shares one publication each.
Metrics
- Publications: 1
Selected Publications
-
Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma (2026)
Collaboration Network
Top Collaborators
Mansi R. Shah
Rutgers, The State University of New Jersey (US)
1 shared publication
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Aishee Bag
Rutgers, The State University of New Jersey (US)
1 shared publication
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Asis Shrestha
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Yetunde Ogunsesan
Medical College of Wisconsin (US)
1 shared publication
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Anup Trikannad
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Sruthi Vellanki
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Sanjay Muttineni
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Hira Cheema
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Syed Naqvi
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Sasya Dronavalli
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Samer Al Hadidi
Southwestern Medical Center
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Maurizio Zangari
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Frits van Rhee
University of Arkansas for Medical Sciences
1 shared publication
In database
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Anikó Szabó
Medical College of Wisconsin (US)
1 shared publication
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Rajshekhar Chakraborty
Columbia University Irving Medical Center (US)
1 shared publication
- Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma
Similar Researchers
Based on overlapping research topics
Mary Price
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Immune Response and Inflammation
lan J Tackett
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Cancer-related molecular mechanisms research
Fumou Sun
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Manuel Heredia
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Osman O Atiq
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Monoclonal and Polyclonal Antibodies Research
Ahmad Mazen Safar
University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology
Immune Response and Inflammation
Cancer-related molecular mechanisms research